MoneyWorks4Me

Cipla’s consolidated net profit rises 13% in Q2FY25

29 Oct 2024 Evaluate

Cipla has reported results for second quarter ended September 30, 2024 (Q2FY25).

The company has reported 14.42% rise in its net profit at Rs 1,178.16 crore for the quarter ended September 30, 2024 as compared to Rs 1,029.69 crore for the same quarter in the previous year. Total income of the company increased by 14.07% at Rs 5,064.17 crore for Q2FY25 as compared to Rs 4,439.53 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 13.00% rise in net profit at Rs 1,306.02 crore for Q2FY25 as compared to Rs 1,155.82 crore for the same quarter in the previous year. Total income of the company increased by 5.65% at Rs 7,241.63 crore for Q2FY25 as compared to Rs 6,854.47 crore for the corresponding quarter previous year.


Peers
Company Name CMP
Sun Pharma. Inds. 1840.00
Dr. Reddys Labs. 1222.50
Cipla 1388.90
Lupin 2061.85
Zydus Lifesciences 1212.00
View more..